Emerging as a significant breakthrough in the struggle against obesity, the drug is attracting considerable attention . This treatment combines the action of two established GLP-1 receptor agonists, liraglutide, plus an new glucose-dependent peptide component. Preliminary study findings have indicated substantial body decrease in people with a h… Read More